| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |